Abstract | INTRODUCTION: PATIENTS AND METHODS: An open, two-week trial was conducted in 89 patients between 1 July and 15 September 2001. A baseline oto-rhinolaryngological examination was performed. Nasal obstruction, rhinorrhea, sneezing, and itching as well as ocular, throat and ear clinical signs and general symptoms including cough and dyspnea were characterized using a symptom score. Mometasone furoate was administered intranasally in 100 micrograms doses into both nostrils. Depending on the severity of symptoms, antiallergic eye drops and systemic antihistamines were also allowed. After two weeks of treatment, a follow-up physical examination was performed and the symptom score was re-evaluated. Potential adverse events that had occurred during the treatment period were recorded. RESULTS:
Mometasone furoate nasal spray alleviated all four nasal symptoms promptly and effectively. In particular, treatment resulted in a 93 percent decrease of overall symptom score. None of the participants discontinued treatment due to the occurrence of adverse effects. CONCLUSION:
|
Authors | Henriette Farkas, Judit Pintér, László Kalabay, László Jakab, Beáta Visy, Béla Fekete |
Journal | Orvosi hetilap
(Orv Hetil)
Vol. 143
Issue 33
Pg. 1929-33
(Aug 18 2002)
ISSN: 0030-6002 [Print] Hungary |
Vernacular Title | Mometazon furoat orrspray hatékonyságának vizsgálata. A gyógyszer hazai bevezetését követó elsó pollenszezon gyakorlati tapasztalatai. |
PMID | 12244656
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Anti-Allergic Agents
- Anti-Inflammatory Agents
- Glucocorticoids
- Pregnadienediols
- Mometasone Furoate
|
Topics |
- Administration, Inhalation
- Administration, Topical
- Adult
- Anti-Allergic Agents
(administration & dosage, therapeutic use)
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Conjunctivitis
(drug therapy)
- Female
- Glucocorticoids
- Humans
- Hungary
- Male
- Mometasone Furoate
- Pregnadienediols
(administration & dosage, therapeutic use)
- Rhinitis, Allergic, Seasonal
(diagnosis, drug therapy)
- Severity of Illness Index
- Treatment Outcome
|